NLRP3 Inflammasome May Be a Biomarker for Risk Stratification in Patients with Acute Coronary Syndrome.

De-Gang MoLin WangQian-Feng HanKang YuJia-Hui LiuHeng-Chen Yao

Published in: Journal of inflammation research (2022)

NLRP3 inflammasome levels are an independent predictive factor for high TRS-2P levels, which indicates that the NLRP3 inflammasome may help predict the prognosis of ACS patients.

Keyphrases

nlrp inflammasome
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
patient reported outcomes